GB

Gil Blum

#191 out of 660 analysts
Needham
Automatically Tracked
Tracking: 0 Updated: 6 minutes ago

Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.

Gain and growth charts are calculated per selected timeframe:
29.73%
Gain -0.06%
Monthly
-0.32%
Yearly
-3.78%
Drawdown
65.26%
$86,566.99
Equity
Holdings
$86,566.99
Cash
$0
Investment
$76,870.77
-$16,841.68
Profit -$48.79
Realized
-$26,537.9
Unrealized
$9,696.22
Dividends
$0
$0
Cash
Deposits
$103,408.67
Withdrawals
$0
Commissions
$0

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
-0.06%
Profit
-$48.79
Win %
77%
This Week
Compared To Last Week
Gain
-0.06%
Profit
-$48.79
Win %
77%
This Month
Compared to last month
Gain
3.54%
Profit
$2,959.34
Win %
74%
This Year
Compared to last year
Gain
12.39%
Profit
$9,541.91
Win %
58%
Cartesian Therapeutics Inc. logo
RNAC Cartesian Therapeutics Inc.
+17.99%
+$1,533.13
Artiva Biotherapeutics Inc. logo
ARTV Artiva Biotherapeutics Inc.
+6.75%
+$486.77
Absci Corporation logo
ABSI Absci Corporation
+4.46%
+$279.8
Nkarta Inc. logo
NKTX Nkarta Inc.
+3.62%
+$246.01
Taysha Gene Therapies Inc. logo
TSHA Taysha Gene Therapies Inc.
+2.33%
+$145.95
Sarepta Therapeutics Inc. logo
SRPT Sarepta Therapeutics Inc.
+2.07%
-$121.54
Autolus Therapeutics plc American Depositary Receipt logo
AUTL Autolus Therapeutics plc American Depositary Receipt
0%
$0
Recursion Pharmaceuticals, Inc. logo
RXRX Recursion Pharmaceuticals, Inc.
0%
$0
Lyell Immunopharma, Inc. logo
LYEL Lyell Immunopharma, Inc.
-1.6%
-$113.49
Solid Biosciences Inc. logo
SLDB Solid Biosciences Inc.
-1.11%
-$73.73
Celcuity Inc. logo
CELC Celcuity Inc.
-1.05%
-$65.75
Nurix Therapeutics Inc. logo
NRIX Nurix Therapeutics Inc.
-0.18%
-$12.65
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
1202
Longs Won
561/1192 47%
Profit Factor
0.92
Profitability
Shorts Won
3/10 30%
Standard Deviation
$902.12
Average Win
$360.26
Best Trade
(Jun 24) $5,553.94
Sharpe Ratio
-440.19
Average Loss
-$344.88
Worst Trade
(Feb 13) -$20,664.5
Z-Score
-12.24 (100%)
Commissions
$0
Avg. Trade Length
4m 1d
Expectancy
-$14.01
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss - - - - - - - - - -
Consecutive Losing Trades 251 226 201 176 151 126 100 75 50 25
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV